By Mark Durivage

Published in: Cell & Gene

Published on: July 14, 2021

Conclusion Paragraph: Recent changes in the organization, structure, and philosophy at the FDA are a positive sign for the pharmaceutical industry. The guidance contains a comprehensive Appendix that provides several practical examples to help classify the change type, which will be useful for reference and as a training tool when implementing the change assessment and notification process.

Advance Stability Knowledge

Would you like to see a particular publication, guidance, organization, supplier, event, or career opportunity on StabilityHub? Contact us with your suggestion!